Press release

Filter by:

Latest

e-therapeutics to present at Shares Investor Evening

Feb 16, 2021

RNA Therapeutics Platform

Feb 1, 2021

COVID-19 Project Update

Dec 8, 2020

Interim Results for six months ended 31 July 2020

Oct 12, 2020

Appointment of Ali Mortazavi as CEO

Oct 12, 2020

Notice of Interim Results

Oct 5, 2020

Expansion of Scientific Advisory Board

Sep 28, 2020

Exercise of Broker Option and Total Fundraise

Jul 14, 2020

Exercise of Broker Option

Jul 9, 2020

Result of Retail Offer

Jul 8, 2020

Fundraise of up to £12.4 million

Jul 7, 2020

Retail Offer

Jul 7, 2020

Collaboration with Galapagos

Jun 10, 2020

Expansion into RNAi and creation of SAB

May 28, 2020

COVID-19 update: experimental testing initiated with WuXi AppTec

May 18, 2020

e-therapeutics to present at Shares Investor Evening

May 15, 2020

Appointment of Chief Business Officer

Apr 2, 2020

Notice of Annual General Meeting and Annual Report

Mar 31, 2020

Anti-viral drug discovery initiative

Mar 23, 2020

Results for the year ended 31 January 2020

Mar 17, 2020

Notification of Full Year Results Date

Mar 11, 2020

Board Changes and Placing

Feb 11, 2020

Half-year Report

Oct 7, 2019

e-therapeutics to work with top pharma company

Aug 13, 2019